Founded in November 2005, Transinsight GmbH is a software company focused on the life sciences that provides products and solutions for knowledge-based technologies. Their flagship product, GoPubMed, a well established biomedical search engine, will be extended towards biomedical image search and knowledge-based image recognition. Especially particle tracking imagery produced by high throughput microscopy will be a focus in the upcoming years.

"The extraordinary scientific work performed at the MPI-CBG by Dr. Yannis Kalaidzidis in the area of particle tracking is an ideal start for collaboration. The close to practice testing of our developments at the MPI-CBG is an invaluable advantage for us" says Transinsight's CEO and co-founder, Dr. Michael R. Alvers.

Prof. Dr. Marino Zerial, Director at the MPI-CBG is happy to see the further development of intelligent software solutions urgently needed for today's high-throughput image-based experimental data. "For us it is essential to be able to extract more information from the new generation of image-based screens that are providing such an exciting opportunity to better understand biology as well as discover new and better drugs. Sophisticated software is an essential tool which allows us to analyse and make sense of the huge datasets as well as reveal hidden and unexpected interconnections" says Zerial.

Dr. Ivan Baines, who fostered the collaboration and outlined the three year collaboration agreement between Transinsight and the MPI-CBG, is enthusiastic about the upcoming development. "This kind of research-industry collaboration allows us to influence developments towards our needs" he said. "With Transinsight we will develop a far more flexible and powerful application that will help solve problems beyond that for which it was originally developed. Such collaboration allows us to further our own research as well as help deliver an important research tool to the community".